Fatty liver disease, also called metabolic dysfunction-associated steatohepatitis (MASH), is a condition where fat ...

As researchers and healthcare professionals seek new ways to tackle chronic diseases, targeted approaches like this one could ...

Wegovy (semaglutide) could offer a new option to treat severe liver disease based on new clinical trial evidence. The GLP-1 ...

GSK's (GSK) linerixibat achieves significant itch reduction in a late-stage trial for cholestatic pruritus, meeting key goals ...

Inebilizumab (Uplizna) treatment significantly reduced the risk of flares in patients who had IgG4-related disease (IgG4-RD) ...

Ozempic, a diabetes drug, shows promise for liver disease. Research indicates it can reverse non-alcoholic steatohepatitis. A ...

Dublin, May 06, 2025 (GLOBE NEWSWIRE) -- The "Liver Disease Treatments Market" report has been added to ResearchAndMarkets.com's offering. The global market for liver disease treatments is ...

An experimental new treatment is showing early promise in the fight against liver fibrosis - a serious and often silent condition that affects around ...

Gastrointestinal cancers often develop silently but knowing risk factors and warning signs can lead to earlier detection and ...

Dr Vandana Sharma Nonalcoholic fatty liver disease (NAFLD), also commonly known as fatty liver (I will be using this term in the rest of the article for familiarity) is quickly growing as a leading ...

To advance the understanding and treatment of liver disease by pursuing innovative, transformative basic and translational ...

Roche is rolling out a new diagnostic test to help assess hidden liver fibrosis in patients showing signs of metabolic ...